L-R: Function Oncology CSO Srihari Sampath, chief technology officer Christian Schmedt, and CEO Srinath Sampath (Function Oncology)
April 12, 2023 06:30 AM EDTUpdated 09:13 AM
Financing
R&D

Sci­ence-whiz twins backed by a16z bring Func­tion On­col­o­gy out of stealth

Andrew Dunn

Senior Biopharma Correspondent

While the drug in­dus­try has de­vel­oped dozens of drugs tar­get­ing spe­cif­ic pro­teins or genes in­volved in can­cer, a new San Diego start­up hopes to su­per­charge …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

A service from the Financial Times